Adalet Elçin Yıldız1, Hülya Maraş Genç2, Esra Gürkaş2, Havva Akmaz Ünlü1, İbrahim Halil Öncel2, Alev Güven2. 1. Department of Radiology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Turkey. 2. Department of Pediatric Neurology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Turkey.
Abstract
PURPOSE: We aimed to present clinical and radiologic characteristics of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in children. METHODS: Eight children (5 boys and 3 girls; median age, 5.9 years; age range, 8 months to 14.1 years) diagnosed with MERS between September 2015 and June 2017 were included in the study. We reviewed the patient's data, including demographic characteristics, prodromal and neurologic symptoms, neurologic examination, magnetic resonance imaging and electroencephalography findings, laboratory findings, treatment, and prognosis. RESULTS: Prodromal symptoms were nausea and vomiting (n=6), diarrhea (n=6), and fever (n=3). Initial neurologic symptoms were seizures (n=4), delirious behavior (n=1), drowsiness (n=1), ataxia (n=1), transient blindness (n=2), abnormal speech (n=2), and headache (n=1). Two patients had a suspected infective agent: urinary tract infection caused by Escherichia coli and gastroenteritis caused by rotavirus. Seven patients had type I lesions, comprising characteristic symmetric ovoid (n=6) and band-shaped (n=1) T2-weighted hyperintense lesions at the spenium of corpus callosum, and one patient had type II lesion with additional symmetric posterior periventricular lesions. The lesions were isointense to mildly hypointense on T1-weighted imaging and did not show enhancement. All lesions displayed restricted diffusion. In all patients, neurologic symptoms completely normalized < 48 hours from the onset of symptoms without any sequelae. CONCLUSION: MERS has characteristic imaging features and favorable outcome.
PURPOSE: We aimed to present clinical and radiologic characteristics of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in children. METHODS: Eight children (5 boys and 3 girls; median age, 5.9 years; age range, 8 months to 14.1 years) diagnosed with MERS between September 2015 and June 2017 were included in the study. We reviewed the patient's data, including demographic characteristics, prodromal and neurologic symptoms, neurologic examination, magnetic resonance imaging and electroencephalography findings, laboratory findings, treatment, and prognosis. RESULTS: Prodromal symptoms were nausea and vomiting (n=6), diarrhea (n=6), and fever (n=3). Initial neurologic symptoms were seizures (n=4), delirious behavior (n=1), drowsiness (n=1), ataxia (n=1), transient blindness (n=2), abnormal speech (n=2), and headache (n=1). Two patients had a suspected infective agent: urinary tract infection caused by Escherichia coli and gastroenteritis caused by rotavirus. Seven patients had type I lesions, comprising characteristic symmetric ovoid (n=6) and band-shaped (n=1) T2-weighted hyperintense lesions at the spenium of corpus callosum, and one patient had type II lesion with additional symmetric posterior periventricular lesions. The lesions were isointense to mildly hypointense on T1-weighted imaging and did not show enhancement. All lesions displayed restricted diffusion. In all patients, neurologic symptoms completely normalized < 48 hours from the onset of symptoms without any sequelae. CONCLUSION:MERS has characteristic imaging features and favorable outcome.
Authors: Andrew Jea; Shobhan Vachhrajani; Elysa Widjaja; Daniel Nilsson; Charles Raybaud; Manohar Shroff; James T Rutka Journal: Childs Nerv Syst Date: 2008-03-29 Impact factor: 1.475
Authors: Choong Yi Fong; Mi Mi Ko Khine; Alan Basil Peter; Wei Kang Lim; Faizatul Izza Rozalli; Kartini Rahmat Journal: J Clin Neurosci Date: 2016-11-23 Impact factor: 1.961
Authors: Amy Ka; Philip Britton; Christopher Troedson; Richard Webster; Peter Procopis; Joanne Ging; Yew Wee Chua; Adam Buckmaster; Nicholas Wood; Cheryl Jones; Russell C Dale Journal: Eur J Paediatr Neurol Date: 2015-02-13 Impact factor: 3.140
Authors: J Takanashi; A J Barkovich; T Shiihara; H Tada; M Kawatani; H Tsukahara; M Kikuchi; M Maeda Journal: AJNR Am J Neuroradiol Date: 2006-04 Impact factor: 3.825
Authors: Konstantinos Karampatsas; Christina Spyridou; Ian R Morrison; Cheuk Y W Tong; Andrew J Prendergast Journal: BMC Infect Dis Date: 2015-10-24 Impact factor: 3.090